Honored to serve as the keynote speaker at the 23rd Annual Retreat hosted by the Brain Tumor Center of Excellence at Atrium Health Wake Forest Baptist Comprehensive Cancer Center. I enjoyed discussing innovative approaches to treating leptomeningeal disease and collaborating with colleagues dedicated to advancing neuro-oncology research and patient care. @MoffitNews @MoffittResearch #BrainTumorResearch #CancerResearch

Great dinner at the oldest restaurant in Boston for SNO/ASCO 2026. I learned alot. It always great to touch base with friends and colleagues. #MoffittNews

Help us spread the word! 📢 A new Phase II clinical trial for patients with breast cancer leptomeningeal disease (LMD) is now enrolling at @MoffittNews. The study is evaluating intrathecal cDC1s combined with intrathecal trastuzumab (HER2+) or intrathecal nivolumab (HER2-). Learn more: 🔗 Moffitt: moffitt.org/clinical-trials-… 🔗 ClinicalTrials.gov: clinicaltrials.gov/study/NCT… Please share the Facebook post to help connect patients and families with this research: 🔗 facebook.com/share/p/1EwoJ88… #ClinicalTrials #BreastCancer #LeptomeningealDisease #LMD #CancerResearch

Great talks at #ASCO26 in Neuro oncology! Here’s a brief interview highlighting our work. Watch the videos here: Peter Forsyth interviews @NewsMoffitt @VJOncology Here is the link to the videos from my interview: vjoncology.com/?s=Peter+Fors….

I’m grateful to @BN9 for sharing Heather’s incredible story. Heather is a true hero—a courageous warrior whose strength, resilience, and determination inspire us all. Stories like hers are only possible because of groundbreaking discoveries and the generosity of collaborators like Dr. Brian Czerniecki. His scientific leadership, collaboration, and unwavering support continue to move the field forward. Thank you, Brian, for helping make hope a reality for patients and families. @MoffittNews Bay News 9: baynews9.com/fl/tampa/news/2…

Hope begins with research—and becomes real through patients. 💙 Heather Curley is living beyond expectations after enrolling in a pioneering dendritic cell vaccine clinical trial for leptomeningeal disease at @MoffittNews. Her story is a powerful reminder of why we never stop pushing for better treatments. Read her inspiring journey: Bay News 9: baynews9.com/fl/tampa/news/2… #Glioblastoma #BrainCancer #LeptomeningealDisease #CancerResearch #Immunotherapy #ClinicalTrials #MoffittCancerCenter

It was a pleasure to host Dr. Isabella Glitza, MD, PhD, from MD Anderson Cancer Center last week! We shared ideas about collaborating to improve care for our patients. She is a expert on Melanoma LMD and gave a fantastic talk. We have lots of other to work together on including trial and sharing reagents! Very exciting! We also had a wonderful dinner with Dr. Glitza in a great restaurant. Great time, great food and great friends Photos: Dr. Golnaz Morad and Dr. Glitza, Members of the Department of Neuro-Oncology with Dr. Glitza (center, black attire), followed by a wonderful dinner with colleagues. Clockwise from the lower left corner 8pm: Inna Smalley, PhD, Dr. Isabella "Bella" Glitza, Dr. Jose Guevara, PhD, Dr. Peter Forsyth, and Dr. Yolanda Piña.@MoffittNews #NeuroOncology #Melanoma #LMD #CancerResearch #Collaboration

It was a pleasure to host Dr. Isabella Glitza, MD, PhD, from MD Anderson Cancer Center last week! We shared ideas about collaborating to improve care for our patients. She is a expert on Melanoma LMD and gave a fantastic talk. We have lots of other to work together on including trial and sharing reagents! Very exciting! We also had a wonderful dinner with Dr. Glitza in a great restaurant. Great time, great food and great friends Photos: Members of the Department of Neuro-Oncology with Dr. Glitza (center, black attire), followed by a wonderful dinner with colleagues. Clockwise from the lower left corner 8pm: Inna Smalley, PhD, Dr. Isabella "Bella" Glitza, Dr. Jose Guevara, PhD, Dr. Peter Forsyth, and Dr. Yolanda Piña. @MoffittNews #NeuroOncology #Melanoma #LMD #CancerResearch #Collaboration

During #ASCO26, I spoke with Dr. Patrick Hwu (@PatrickHwuMD ), Moffitt Cancer Center President & CEO about research aimed at improving treatment for brain tumors and melanoma that spreads to the brain. #ASCO26 #MoffittASCO26 @MoffittNews

While at #ASCO26, Peter Forsyth, MD (@PeterForsyth27), stopped by the booth to share research exploring patient-derived tumor models to identify potential treatment strategies for melanoma leptomeningeal disease. #MoffittASCO26

🚨New phase 3 data presented at #ASCO26 compared postoperative stereotactic radiation with cesium-131 tile-based radiation following resection of brain metastases. Moffitt’s Peter Forsyth, MD (@PeterForsyth27), discusses the work by @DrJeffWeinberg of @UTMDAnderson and how tile-based radiation could help redefine postoperative care by improving local control and integrating surgery and radiation into a single treatment approach. #MoffittASCO26

From #ASCO26, Peter Forsyth, MD (@PeterForsyth27), and Brian Czerniecki, MD, PhD (@BCzernieckiMD), discuss the power of cross-disciplinary collaboration in advancing cancer care. Their work combines expertise in neuro-oncology and immunotherapy to develop dendritic cell-based treatments for leptomeningeal disease in patients with breast cancer, with a phase 2 clinical trial now underway. #MoffittASCO26

From #ASCO26, Peter Forsyth, MD (@PeterForsyth27), and Muhammad Jaffer, MD, discuss advances in neuro-oncology, including long-term follow-up from the INDIGO trial showing durable benefits for patients with low-grade glioma and continued momentum toward earlier intervention. They also highlight research focused on understanding and reducing neurologic toxicities associated with cancer therapies, with the goal of preserving quality of life while improving outcomes. #MoffittASCO26

Dendritic Cell Trial Brings Hope for Young Mom With Leptomeningeal Disease | Moffitt @MoffitNews moffitt.org/endeavor/archive…

Pics from March 13.